BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 17293493)

  • 1. Fludarabine prevents smooth muscle proliferation in vitro and neointimal hyperplasia in vivo through specific inhibition of STAT-1 activation.
    Torella D; Curcio A; Gasparri C; Galuppo V; De Serio D; Surace FC; Cavaliere AL; Leone A; Coppola C; Ellison GM; Indolfi C
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2935-43. PubMed ID: 17293493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-Eluting Stent Targeting Sp-1-Attenuated Restenosis by Engaging YAP-Mediated Vascular Smooth Muscle Cell Phenotypic Modulation.
    Huang C; Zhao J; Zhu Y
    J Am Heart Assoc; 2020 Jan; 9(1):e014103. PubMed ID: 31880978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of Peroxisome Proliferator-Activated Receptor-δ as Novel Therapeutic Strategy to Prevent In-Stent Restenosis and Stent Thrombosis.
    Hytönen J; Leppänen O; Braesen JH; Schunck WH; Mueller D; Jung F; Mrowietz C; Jastroch M; von Bergwelt-Baildon M; Kappert K; Heuser A; Drenckhahn JD; Pieske B; Thierfelder L; Ylä-Herttuala S; Blaschke F
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1534-48. PubMed ID: 27283742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-eluting stent specifically designed to target vascular smooth muscle cell phenotypic modulation attenuated restenosis through the YAP pathway.
    Huang C; Zhang W; Zhu Y
    Am J Physiol Heart Circ Physiol; 2019 Sep; 317(3):H541-H551. PubMed ID: 31298560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury.
    Yao Y; Hu Z; Ye J; Hu C; Song Q; Da X; Yu Y; Li H; Xu C; Chen Q; Wang QK
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28649088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A perlecan-inducing compound significantly inhibits smooth muscle cell function and in-stent intimal hyperplasia: novel insights into the diverse biological effects of perlecan.
    Segev A; Nili N; Osherov AB; Qiang B; Wong AJ; Pillarisetti S; Strauss BH
    EuroIntervention; 2010 May; 6(1):134-40. PubMed ID: 20542809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of Cavin-1 Expression via Increasing Caveolin-1 Degradation Prompts the Proliferation and Migration of Vascular Smooth Muscle Cells in Balloon Injury-Induced Neointimal Hyperplasia.
    Zhou LJ; Chen XY; Liu SP; Zhang LL; Xu YN; Mu PW; Geng DF; Tan Z
    J Am Heart Assoc; 2017 Jul; 6(8):. PubMed ID: 28751541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of experimental neointimal hyperplasia by recombinant human thrombomodulin coated ePTFE stent grafts.
    Wong G; Li JM; Hendricks G; Eslami MH; Rohrer MJ; Cutler BS
    J Vasc Surg; 2008 Mar; 47(3):608-15. PubMed ID: 18295112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic trioxide eluting stent reduces neointima formation in a rabbit iliac artery injury model.
    Yang W; Ge J; Liu H; Zhao K; Liu X; Qu X; Li W; Huang Y; Sun A; Zou Y
    Cardiovasc Res; 2006 Dec; 72(3):483-93. PubMed ID: 17020754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gliotoxin inhibits neointimal hyperplasia after vascular injury in rats.
    Pozo M; Izquierdo MC; de Nicolás R; Egido J; Ortiz A; González-Cabrero J
    J Vasc Res; 2009; 46(4):278-89. PubMed ID: 19033690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cilostazol inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor expression in artery wall and neointimal region after vascular injury.
    Lee KM; Lee HJ; Kim MK; Kim HS; Jung GS; Hur SH; Kim HT; Cho WH; Kim JG; Kim BW; Lim JO; Choi HS; Lee KU; Park KG; Lee IK
    Atherosclerosis; 2009 Dec; 207(2):391-8. PubMed ID: 19586629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of NAD(P)H:quinone oxidoreductase 1 prevents arterial restenosis by suppressing vascular smooth muscle cell proliferation.
    Kim SY; Jeoung NH; Oh CJ; Choi YK; Lee HJ; Kim HJ; Kim JY; Hwang JH; Tadi S; Yim YH; Lee KU; Park KG; Huh S; Min KN; Jeong KH; Park MG; Kwak TH; Kweon GR; Inukai K; Shong M; Lee IK
    Circ Res; 2009 Apr; 104(7):842-50. PubMed ID: 19229058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xenogenic smooth muscle cell immunization reduces neointimal formation in balloon-injured rabbit carotid arteries.
    Shinohara M; Kawashima S; Yamashita T; Takaya T; Toh R; Ishida T; Ueyama T; Inoue N; Hirata K; Yokoyama M
    Cardiovasc Res; 2005 Nov; 68(2):249-58. PubMed ID: 16039635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of curcumin for preventing restenosis in a hypercholesterolemic rabbit iliac artery stent model.
    Jang HS; Nam HY; Kim JM; Hahm DH; Nam SH; Kim KL; Joo JR; Suh W; Park JS; Kim DK; Gwon HC
    Catheter Cardiovasc Interv; 2009 Nov; 74(6):881-8. PubMed ID: 19496118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morelloflavone blocks injury-induced neointimal formation by inhibiting vascular smooth muscle cell migration.
    Pinkaew D; Cho SG; Hui DY; Wiktorowicz JE; Hutadilok-Towatana N; Mahabusarakam W; Tonganunt M; Stafford LJ; Phongdara A; Liu M; Fujise K
    Biochim Biophys Acta; 2009 Jan; 1790(1):31-9. PubMed ID: 18930785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of In-Stent Restenosis by Cholesteryl Ester Transfer Protein Inhibition.
    Wu BJ; Li Y; Ong KL; Sun Y; Shrestha S; Hou L; Johns D; Barter PJ; Rye KA
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2333-2341. PubMed ID: 29025709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting: approach to therapy.
    Curcio A; Torella D; Indolfi C
    Circ J; 2011; 75(6):1287-96. PubMed ID: 21532177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin on smooth muscle cell proliferation in vitro and neointimal formation in vivo after vascular injury.
    Indolfi C; Cioppa A; Stabile E; Di Lorenzo E; Esposito G; Pisani A; Leccia A; Cavuto L; Stingone AM; Chieffo A; Capozzolo C; Chiariello M
    J Am Coll Cardiol; 2000 Jan; 35(1):214-21. PubMed ID: 10636283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periadventitial atRA citrate-based polyester membranes reduce neointimal hyperplasia and restenosis after carotid injury in rats.
    Gregory EK; Webb AR; Vercammen JM; Flynn ME; Ameer GA; Kibbe MR
    Am J Physiol Heart Circ Physiol; 2014 Nov; 307(10):H1419-29. PubMed ID: 25239800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 20-Hydroxyeicosatetraenoic acid inhibition attenuates balloon injury-induced neointima formation and vascular remodeling in rat carotid arteries.
    Orozco LD; Liu H; Perkins E; Johnson DA; Chen BB; Fan F; Baker RC; Roman RJ
    J Pharmacol Exp Ther; 2013 Jul; 346(1):67-74. PubMed ID: 23658377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.